{"count": 16, "results": [{"_id": "34440563", "pmid": 34440563, "pmcid": "PMC8401631", "title": "Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence", "journal": "Life (Basel)", "authors": ["Jones BDM", "Farooqui S", "Kloiber S", "Husain MO", "Mulsant BH", "Husain MI"], "date": "2021-08-11T00:00:00Z", "doi": "10.3390/life11080819", "meta_date_publication": "2021 Aug 11", "meta_volume": "11", "meta_issue": "8", "meta_pages": "", "score": 50257.1, "text_hl": "Current evidence is conflicting on the use of statins, @CHEMICAL_Fatty_Acids_Unsaturated @CHEMICAL_MESH:D005231 @@@polyunsaturated fatty acids@@@, @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@, glucagon-like peptide agonists, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or @GENE_INS @GENE_3630 @@@insulin@@@ for the treatment of @DISEASE_Depressive_Disorder_Major @DISEASE_MESH:D003865 @@@MDD@@@ and @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@BD@@@. ", "citations": {"NLM": "Jones BDM, Farooqui S, Kloiber S, Husain MO, Mulsant BH, Husain MI. Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence Life (Basel). 2021 Aug 11;11(8):. PMID: 34440563", "BibTeX": "@article{34440563, title={Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence}, author={Jones BDM and Farooqui S and Kloiber S and Husain MO and Mulsant BH and Husain MI}, journal={Life (Basel)}, volume={11}, number={8}}"}}, {"_id": "40531218", "pmid": 40531218, "title": "Genetic insights into the effect of Metformin on psychiatry disorders.", "journal": "Eur Arch Psychiatry Clin Neurosci", "authors": ["Zhou Q", "Du Z", "Lu R", "Shen Y", "Jiang Y", "Zhu H"], "date": "2025-08-01T00:00:00Z", "doi": "10.1007/s00406-025-02039-3", "meta_date_publication": "2025 Aug", "meta_volume": "275", "meta_issue": "5", "meta_pages": "1465-1476", "score": 50252.527, "text_hl": "RESULTS: MR analysis results indicate a significant negative causal relationship between genetically predicted @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Neuroticism(NEU) (OR = 0.700, 95% CI: 0.505-0.970, P = 0.032) and @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@Bipolar Disorder@@@(BID) (OR = 0.0374, 95% CI: 0.00266-0.525, P = 0.015). ", "citations": {"NLM": "Zhou Q, Du Z, Lu R, Shen Y, Jiang Y, Zhu H. Genetic insights into the effect of Metformin on psychiatry disorders. Eur Arch Psychiatry Clin Neurosci. 2025 Aug;275(5):1465-1476. PMID: 40531218", "BibTeX": "@article{40531218, title={Genetic insights into the effect of Metformin on psychiatry disorders.}, author={Zhou Q and Du Z and Lu R and Shen Y and Jiang Y and Zhu H}, journal={Eur Arch Psychiatry Clin Neurosci}, volume={275}, number={5}, pages={1465-1476}}"}}, {"_id": "31969278", "pmid": 31969278, "title": "Risk of bipolar disorder in patients with polycystic ovary syndrome: A nationwide population-based cohort study.", "journal": "J Affect Disord", "authors": ["Chen SF", "Yang YC", "Hsu CY", "Shen YC"], "date": "2020-02-15T00:00:00Z", "doi": "10.1016/j.jad.2019.12.007", "meta_date_publication": "2020 Feb 15", "meta_volume": "263", "meta_issue": "", "meta_pages": "458-462", "score": 50251.695, "text_hl": "Also, the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_9606 @@@patients@@@ showed a significantly reduced risk of developing @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@BD@@@ compared to non-users after adjusting for the above-mentioned variables (HR: 0.36, 95% CI: 0.16-0.81). ", "citations": {"NLM": "Chen SF, Yang YC, Hsu CY, Shen YC. Risk of bipolar disorder in patients with polycystic ovary syndrome: A nationwide population-based cohort study. J Affect Disord. 2020 Feb 15;263():458-462. PMID: 31969278", "BibTeX": "@article{31969278, title={Risk of bipolar disorder in patients with polycystic ovary syndrome: A nationwide population-based cohort study.}, author={Chen SF and Yang YC and Hsu CY and Shen YC}, journal={J Affect Disord}, volume={263}, pages={458-462}}"}}, {"_id": "40961367", "pmid": 40961367, "title": "Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report.", "journal": "Int J Psychiatry Clin Pract", "authors": ["Topkaya E", "Bilal Karakuş O"], "date": "2025-09-17T00:00:00Z", "doi": "10.1080/13651501.2025.2563341", "meta_date_publication": "2025 Sep 17", "meta_volume": "", "meta_issue": "", "meta_pages": "1-3", "score": 50250.527, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ usage in the treatment of @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ induced @DISEASE_Hyperprolactinemia @DISEASE_MESH:D006966 @@@hyperprolactinemia@@@ in an adolescent @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@bipolar disorder type 1@@@: a case report.", "citations": {"NLM": "Topkaya E, Bilal Karakuş O. Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report. Int J Psychiatry Clin Pract. 2025 Sep 17;():1-3. PMID: 40961367", "BibTeX": "@article{40961367, title={Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report.}, author={Topkaya E and Bilal Karakuş O}, journal={Int J Psychiatry Clin Pract}, pages={1-3}}"}}, {"_id": "35166568", "pmid": 35166568, "title": "Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression.", "journal": "J Child Adolesc Psychopharmacol", "authors": ["Nagy LR", "Rice T", "Coffey BJ"], "date": "2022-02-01T00:00:00Z", "doi": "10.1089/cap.2022.29215.bjc", "meta_date_publication": "2022 Feb", "meta_volume": "32", "meta_issue": "1", "meta_pages": "72-76", "score": 50249.207, "text_hl": "Combined @CHEMICAL_Topiramate @CHEMICAL_MESH:D000077236 @@@Topiramate@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@Gain@@@ in Pediatric @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@Bipolar Disorder@@@ and @DISEASE_Personality_Disorders @DISEASE_MESH:D010554 @@@Aggression@@@.", "citations": {"NLM": "Nagy LR, Rice T, Coffey BJ. Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression. J Child Adolesc Psychopharmacol. 2022 Feb;32(1):72-76. PMID: 35166568", "BibTeX": "@article{35166568, title={Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression.}, author={Nagy LR and Rice T and Coffey BJ}, journal={J Child Adolesc Psychopharmacol}, volume={32}, number={1}, pages={72-76}}"}}, {"_id": "38421924", "pmid": 38421924, "title": "Predicting Conversion to Insulin Sensitivity With Metformin: A Promising Tool for Clinicians in Addressing Insulin Resistance and Improving Outcomes in Patients With Treatment Resistant Bipolar Depression.", "journal": "J Clin Psychopharmacol", "authors": ["Gannon JM", "Sanchez M", "Lines K", "Cairns K", "Reardon C", "Chengappa KNR", "Calkin CV"], "date": "2024-03-01T00:00:00Z", "doi": "10.1097/JCP.0000000000001818", "meta_date_publication": "2024 Mar-Apr 01", "meta_volume": "44", "meta_issue": "2", "meta_pages": "157-160", "score": 50248.63, "text_hl": "Predicting Conversion to @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin Sensitivity@@@ With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: A Promising Tool for Clinicians in Addressing @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin Resistance@@@ and Improving Outcomes in @SPECIES_9606 @@@Patients@@@ With Treatment Resistant @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@Bipolar Depression@@@.", "citations": {"NLM": "Gannon JM, Sanchez M, Lines K, Cairns K, Reardon C, Chengappa KNR, Calkin CV. Predicting Conversion to Insulin Sensitivity With Metformin: A Promising Tool for Clinicians in Addressing Insulin Resistance and Improving Outcomes in Patients With Treatment Resistant Bipolar Depression. J Clin Psychopharmacol. 2024 Mar-Apr 01;44(2):157-160. PMID: 38421924", "BibTeX": "@article{38421924, title={Predicting Conversion to Insulin Sensitivity With Metformin: A Promising Tool for Clinicians in Addressing Insulin Resistance and Improving Outcomes in Patients With Treatment Resistant Bipolar Depression.}, author={Gannon JM and Sanchez M and Lines K and Cairns K and Reardon C and Chengappa KNR and Calkin CV}, journal={J Clin Psychopharmacol}, volume={44}, number={2}, pages={157-160}}"}}, {"_id": "35120288", "pmid": 35120288, "title": "Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial.", "journal": "J Clin Psychiatry", "authors": ["Calkin CV", "Chengappa KNR", "Cairns K", "Cookey J", "Gannon J", "Alda M", "O'Donovan C", "Reardon C", "Sanches M", "Růzicková M"], "date": "2022-02-01T00:00:00Z", "doi": "10.4088/JCP.21m14022", "meta_date_publication": "2022 Feb 1", "meta_volume": "83", "meta_issue": "2", "meta_pages": "", "score": 50248.09, "text_hl": "Treating @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin Resistance@@@ With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a Strategy to Improve Clinical Outcomes in Treatment-Resistant @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@Bipolar Depression@@@ (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial.", "citations": {"NLM": "Calkin CV, Chengappa KNR, Cairns K, Cookey J, Gannon J, Alda M, O'Donovan C, Reardon C, Sanches M, Růzicková M. Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial. J Clin Psychiatry. 2022 Feb 1;83(2):. PMID: 35120288", "BibTeX": "@article{35120288, title={Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial.}, author={Calkin CV and Chengappa KNR and Cairns K and Cookey J and Gannon J and Alda M and O'Donovan C and Reardon C and Sanches M and Růzicková M}, journal={J Clin Psychiatry}, volume={83}, number={2}}"}}, {"_id": "34113269", "pmid": 34113269, "pmcid": "PMC8185298", "title": "Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder", "journal": "Front Psychiatry", "authors": ["Calkin C", "McClelland C", "Cairns K", "Kamintsky L", "Friedman A"], "date": "2021-05-25T00:00:00Z", "doi": "10.3389/fpsyt.2021.636174", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "636174", "score": 50244.66, "text_hl": "We further hypothesize that (iv) reversing @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@IR@@@ through lifestyle changes or the actions of @GENE_INS @GENE_3630 @@@insulin@@@ sensitizing medications such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or optimizing BBB function using vascular protective drugs, such as @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@, could provide novel strategies for the prevention or treatment of neuroprogressive @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@BD@@@.", "citations": {"NLM": "Calkin C, McClelland C, Cairns K, Kamintsky L, Friedman A. Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder Front Psychiatry. 2021;12():636174. PMID: 34113269", "BibTeX": "@article{34113269, title={Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder}, author={Calkin C and McClelland C and Cairns K and Kamintsky L and Friedman A}, journal={Front Psychiatry}, volume={12}, pages={636174}}"}}, {"_id": "26792047", "pmid": 26792047, "pmcid": "PMC4730928", "title": "Metformin for Lithium-induced Weight Gain: A Case Report", "journal": "Clin Psychopharmacol Neurosci", "authors": ["Praharaj SK"], "date": "2016-02-29T00:00:00Z", "doi": "10.9758/cpn.2016.14.1.101", "meta_date_publication": "2016 Feb 29", "meta_volume": "14", "meta_issue": "1", "meta_pages": "101-3", "score": 50057.285, "text_hl": "We report a young male with @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@bipolar disorder@@@ who had significant @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ with @CHEMICAL_Lithium @CHEMICAL_MESH:D008094 @@@lithium@@@, which responded to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Praharaj SK. Metformin for Lithium-induced Weight Gain: A Case Report Clin Psychopharmacol Neurosci. 2016 Feb 29;14(1):101-3. PMID: 26792047", "BibTeX": "@article{26792047, title={Metformin for Lithium-induced Weight Gain: A Case Report}, author={Praharaj SK}, journal={Clin Psychopharmacol Neurosci}, volume={14}, number={1}, pages={101-3}}"}}, {"_id": "22295263", "pmid": 22295263, "title": "A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder.", "journal": "Prim Care Companion CNS Disord", "authors": ["Agarwal SM", "Behere RV", "Venkatasubramanian G", "Rao NP", "Varambally S", "Gangadhar BN"], "date": "2011-01-01T00:00:00Z", "doi": "10.4088/PCC.11l01164", "meta_date_publication": "2011", "meta_volume": "13", "meta_issue": "5", "meta_pages": "", "score": 50054.45, "text_hl": "A case of successful treatment of comorbid @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian disease@@@ with add-on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Bipolar_Disorder</m> @DISEASE_MESH:D001714 @@@bipolar disorder@@@.", "citations": {"NLM": "Agarwal SM, Behere RV, Venkatasubramanian G, Rao NP, Varambally S, Gangadhar BN. A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder. Prim Care Companion CNS Disord. 2011;13(5):. PMID: 22295263", "BibTeX": "@article{22295263, title={A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder.}, author={Agarwal SM and Behere RV and Venkatasubramanian G and Rao NP and Varambally S and Gangadhar BN}, journal={Prim Care Companion CNS Disord}, volume={13}, number={5}}"}}]}